Hong Kong Pharma Stock News

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

The excitement of investing in a company that can reverse its fortunes is a big draw for some speculators, so even...

The market for Swire Pacific Limited's ( HKG:19 ) shares didn't move much after it posted weak earnings recently. We...

Amid improving global market sentiment following a U.S.-Iran ceasefire agreement, Asian markets have shown resilience and potential for growth. The term 'penny stocks' might feel like a relic of past market eras, but the potential they represent is as real as ever. Typically referring to smaller or relatively new companies, these stocks can provide a mix of affordability and growth potential when paired with strong financials.

Wondering whether BYD at HK$107.30 is a bargain or a value trap? This article breaks down what the current price really implies about the stock. The share price recently closed at HK$107.30, with returns of 0.5% over 7 days, 2.9% over 30 days, 8.7% year to date, a 10.5% decline over the past year, 44.6% gains over 3 years and 87.0% gains over 5 years. Recent coverage has focused on BYD as a major player in electric vehicles and batteries, with investors weighing its role in global EV...

Lenovo Group (SEHK:992) has formed an alliance with Konecta to develop AI powered digital workplace solutions. The partnership focuses on an integrated model for IT outsourcing and digital workplace services using AI platforms. The collaboration is set to affect more than 100,000 employees across a global footprint. The move aligns with Lenovo’s broader shift toward services led and outcome based business models. For Lenovo Group, best known for PCs, infrastructure and devices, the alliance...

Global markets have recently experienced a boost in investor sentiment, driven by a ceasefire agreement between the U.S. and Iran, which has helped ease geopolitical tensions and lower oil prices. As major indices like the Nasdaq Composite see significant gains, investors are increasingly looking for opportunities that balance risk with potential rewards. Though "penny stocks" might seem like an outdated term, they continue to offer intriguing prospects for growth. These stocks often...

Skyworth Group (SEHK:751) recently drew investor interest after its shares closed at HK$6.42, with a one day return of 2.1% and a year to date return of 23.9%, spotlighting its diversified electronics and new energy operations. See our latest analysis for Skyworth Group. That 2.1% one day share price return and 4.1% 7 day share price return sit against a softer 30 day share price return of an 8.6% decline, while the 1 year total shareholder return of 126.1% points to momentum that has been...

As global markets respond positively to a U.S.-Iran ceasefire, investor sentiment has improved, leading to gains across major indices. In this context, penny stocks—often representing smaller or newer companies—can still offer intriguing opportunities for growth when backed by solid financial health. Despite being considered a niche investment area today, these stocks can provide value and potential upside for those looking beyond larger firms.

Aluminum Corporation of China (SEHK:2600) issued first quarter 2026 earnings guidance, flagging net profit of CN¥5,302 million to CN¥5,585 million and basic EPS of CN¥0.310 to CN¥0.326, both implying 50% to 58% year-on-year growth. See our latest analysis for Aluminum Corporation of China. The earnings guidance comes after a sharp re-rating, with the 1-year total shareholder return of about 3x and a more muted share price return of 0.32% year to date at HK$12.68. Recent 7-day strength...

Luye Pharma Group (SEHK:2186) has drawn fresh attention after reporting the first patient enrollment in a Phase II trial in China for LY03020, a dual TAAR1 and 5-HT2CR agonist targeting schizophrenia. See our latest analysis for Luye Pharma Group. The LY03020 trial update comes as Luye Pharma Group’s share price sits at HK$2.89, with a 30-day share price return of 18.93% contrasting with a 90-day share price decline of 3.99%. The 1-year total shareholder return of 55.38% stands against a...

Why Xiaomi’s stock is drawing fresh attention Xiaomi (SEHK:1810) is back on investors’ radar after recent trading left the share price lower over the past month and the past 3 months, prompting closer scrutiny of its current valuation and business mix. See our latest analysis for Xiaomi. At the latest share price of HK$30.88, Xiaomi’s recent 30 day share price return of 7.32% and year to date share price return of 23.34% contrast with a 3 year total shareholder return of 148.23%. This...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Renewed agreements with Yili Group set the context China Youran Dairy Group (SEHK:9858) has renewed long term supply and financial agreements with controlling shareholder Yili Group. These agreements lock in their commercial relationship from 2027 to 2029 and formalize ongoing raw milk and dairy product transactions. See our latest analysis for China Youran Dairy Group. The renewed Yili contracts arrive after a weaker patch for the shares, with a 30 day share price return of 5.58% and a 90...

Dongfang Electric (SEHK:1072) has drawn fresh attention after reporting full year 2025 results alongside a declared final ordinary dividend of RMB 5.3 per 10 shares, providing both earnings and income updates for shareholders. See our latest analysis for Dongfang Electric. The full year results and higher dividend have arrived against a strong backdrop, with a 90 day share price return of 60.83% and a very large 1 year total shareholder return that far outpaces the short term moves. If...

Central New Energy Holding Group (SEHK:1735) reported full year 2025 results, with sales of HK$11,016.85 million, net income of HK$34.24 million, and earnings per share of HK$0.0081 from continuing operations. See our latest analysis for Central New Energy Holding Group. The earnings release comes after a steady run in the shares, with a 9.55% 1 month share price return and 12.30% 3 month share price return. However, the 1 year total shareholder return is still down 6.58% while the 5 year...

Genscript Biotech (SEHK:1548) is back in focus after announcing a multi year collaboration with Mimulus Corp to industrialize DNA based data storage, targeting scalable infrastructure and substantial cost efficiencies by 2030. See our latest analysis for Genscript Biotech. The collaboration headlines come as Genscript Biotech's share price, now at HK$12.62, shows mixed momentum, with a 13.8% 1 month share price return but a 12.42% decline over 3 months. The 1 year total shareholder return...

Zhejiang Expressway Co., Ltd. recently reported its full-year 2025 results, with sales rising to CNY 19.76 billion while net income eased slightly to CNY 5.32 billion, and recommended a higher dividend of CNY 0.395 per share, all subject to approval at the 2025 annual shareholders’ meeting. The combination of revenue growth, a modest earnings dip and a proposed dividend increase highlights management’s emphasis on returning cash to shareholders while operating profitability remains under...

Akeso (SEHK:9926) has come into focus after presenting new lung cancer data at the 2026 European Lung Cancer Congress. The company updated investors on cadonilimab and ivonescimab across difficult non small cell lung cancer settings. See our latest analysis for Akeso. Following the ELCC updates, Akeso's HK$137.8 share price sits on the back of a 25.05% 1 month share price return and 21.62% year to date share price return. The 1 year total shareholder return of 58.48% and 3 year total...

China Overseas Land & Investment (SEHK:688) caught investor attention after reporting March contracted property sales of about RMB28.578b, up 34.8% year on year, with first quarter contracted sales up 11% to roughly RMB51.52b. See our latest analysis for China Overseas Land & Investment. Even with the strong first quarter contracted sales update, the recent 30 day share price return decline of 6.8% and year to date share price return decline of 4.48% sit alongside a 1 year total shareholder...

Innovent Biologics (SEHK:1801) shares moved in response to fresh product news after the company presented initial preclinical data for IBI3055, a tri specific anti CD19/BCMA/CD3 T cell engager for autoimmune diseases, in Boston. See our latest analysis for Innovent Biologics. The latest IBI3055 update lands after a mixed but generally positive stretch for investors, with a 30 day share price return of 9.46%, year to date share price return of 12.31%, and a 1 year total shareholder return of...

Why WH Group’s latest share price high matters WH Group (SEHK:288) has reached an all time share price high after an upstream turnaround linked to the US hog market upcycle, higher dividends, and a larger role for more stable downstream operations. See our latest analysis for WH Group. At a share price of HK$10.83, WH Group has built solid momentum, with a 30 day share price return of 14.0% and a 1 year total shareholder return of 82.01%, reflecting stronger sentiment around earnings...

Earlier this month, JP Morgan issued a research report naming China Telecom as one of its preferred defensive yield plays among Chinese equities, assigning the stock an Overweight rating and emphasizing its income profile in the current macro backdrop. The report’s focus on China Telecom’s resilience and dividend appeal highlights how major institutions may be viewing the company as a potential anchor for investors seeking relative stability within China’s equity market. We’ll now look at...

CSSC Offshore & Marine Engineering (Group) (SEHK:317) has drawn fresh attention after issuing 2026 earnings guidance targeting operating income of CN¥21.218b, along with a proposed cash dividend that would distribute roughly 30.14% of annual net profit. See our latest analysis for CSSC Offshore & Marine Engineering (Group). The 7 day share price return of 7.77% at a latest share price of HK$13.87 contrasts with a 30 day share price return decline of 11.66%. However, the 1 year total...